benazepril hydrochloride and hydrochlorothiazide (0574-0228)

Drug Facts

Product Profile

Brand Name benazepril hydrochloride and hydrochlorothiazide

Generic Name benazepril hydrochloride and hydrochlorothiazide

Labeler padagis us llc

Dosage Form TABLET

Routes

ORAL

Active Ingredients

benazepril hydrochloride 20 mg/1, hydrochlorothiazide 25 mg/1

Manufacturer

Padagis US LLC

Identifiers & Regulatory

Product NDC 0574-0228

Product ID 0574-0228_55072852-c532-448e-935e-102e981cf698

Product Type HUMAN PRESCRIPTION DRUG

Marketing Category NDA AUTHORIZED GENERIC

Application Number NDA020033

Marketing Start 2019-04-07

Marketing End 2027-03-31

Pharmacologic Class

Established (EPC)

thiazide diuretic [epc]

Chemical Structure

thiazides [cs]

Physiologic Effect

increased diuresis [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 05740228

Hyphenated Format 0574-0228

Supplemental Identifiers

RxCUI

898362 898367 898372

UPC

0305740229019 0305740228012 0305740227015

UNII

0J48LPH2TH N1SN99T69T

NUI

N0000175359 N0000175419 M0471776

Packaging Origin

Original Packager

true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name benazepril hydrochloride and hydrochlorothiazide (source: ndc)

Generic Name benazepril hydrochloride and hydrochlorothiazide (source: ndc)

Application Number NDA020033 (source: ndc)

Routes

ORAL

source: ndc

Resolved Composition

Strengths

20 mg/1
25 mg/1

source: ndc

Packaging

100 TABLET in 1 BOTTLE (0574-0228-01)

source: ndc

Packages (1)

0574-0228-01 100 TABLET in 1 BOTTLE (0574-0228-01)

Ingredients (2)

benazepril hydrochloride (20 mg/1) hydrochlorothiazide (25 mg/1)

Linked Drug Pages (1)

benazepril hydrochloride and hydrochlorothiazide ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["ORAL"], "spl_id": "55072852-c532-448e-935e-102e981cf698", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776"], "upc": ["0305740229019", "0305740228012", "0305740227015"], "unii": ["0J48LPH2TH", "N1SN99T69T"], "rxcui": ["898362", "898367", "898372"], "spl_set_id": ["3e2d3974-38b0-49d0-8020-f74107584724"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "manufacturer_name": ["Padagis US LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (0574-0228-01)", "package_ndc": "0574-0228-01", "marketing_end_date": "20270331", "marketing_start_date": "20190407"}], "brand_name": "benazepril hydrochloride and hydrochlorothiazide", "product_id": "0574-0228_55072852-c532-448e-935e-102e981cf698", "dosage_form": "TABLET", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Decreased Blood Pressure [PE]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "0574-0228", "generic_name": "benazepril hydrochloride and hydrochlorothiazide", "labeler_name": "Padagis US LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "benazepril hydrochloride and hydrochlorothiazide", "active_ingredients": [{"name": "BENAZEPRIL HYDROCHLORIDE", "strength": "20 mg/1"}, {"name": "HYDROCHLOROTHIAZIDE", "strength": "25 mg/1"}], "application_number": "NDA020033", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_end_date": "20270331", "marketing_start_date": "20190407"}